Editorial: Cancer Immunosurveillance - Takeaways - MDSpire

Editorial: Cancer Immunosurveillance

  • By

  • Sam Hanash

  • Luigi Buonaguro

  • Olivera Finn

  • June 12, 2026

  • 0 min

Share

  • 1

    Cancer immunosurveillance processes are crucial for understanding how the immune system eliminates or evades tumors.

  • 2

    T cell-mediated immune surveillance can suppress tumor formation, even in the absence of MHC class I expression.

  • 3

    SARS-CoV-2 antigens show significant homology with tumor-associated antigens, suggesting potential anti-cancer immunization.

  • 4

    Chronic stress impairs immune surveillance and promotes tumor progression by altering the tumor microenvironment.

  • 5

    Vaccines targeting tumor-associated antigens show promise in enhancing cancer immunosurveillance and prevention.

Original Source(s)

Editorial: Cancer Immunosurveillance

  • by Sam Hanash, Luigi Buonaguro, Olivera Finn

  • June 12, 2026

Related Content

Primary malignant peripheral nerve sheath tumor of the liver: a case report and literature review

Group painting therapy for children and adolescents with bone tumors: a quasi-experimental trial evaluating anxiety, depression, post-traumatic growth, and health-related quality of life

Editorial: Importance of quality assurance in radiation oncology clinical trials